This web site is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.


OBI Pharma, Inc.

Drug Names(s): Globo H-CRM197 vaccine

Description: OBI-833 is a carbohydrate-based vaccine comprised of the complex carbohydrate, Globo H hexasaccharide 1 (Globo H), conjugated to DT-CRM197, a non-toxic, mutated form of diphtheria toxin (DT). Globo H is an antigen overexpressed on several types of cancer cells, and the DT portion of the vaccine is projected to increase the immunogenicity of the Globo H carbohydrate antigen.

Deal Structure: OBI licensed OBI-833 from Academia Sinica.

OBI-833 News

Additional information available to subscribers only:

  • Targets
  • Routes
  • Catalysts
  • Designations
  • Events

Request a Free Demo Subscriber Login Search for another drug